Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.65Price to Sales
VS
Market
Sector
Industry
History
$ 0.88Close
$ 0.53 - $ 4.4 52-Week Range
Ticker Information
Ticker
STROCompany Name
SUTRO BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSUTRO BIOPHARMA INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
STRO - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 67.82M | 0.65 | $ 104.47M |
| 3/31/2025 | $ 80.91M | 1.22 | $ 66.43M |
| 12/31/2024 | $ 104.72M | 1.69 | $ 62.04M |
| 9/30/2024 | $ 326.54M | 2.03 | $ 160.96M |
| 6/30/2024 | $ 263.92M | 1.56 | $ 169.36M |
| 3/31/2024 | $ 345.99M | 2.25 | $ 154.06M |
| 12/31/2023 | $ 204.19M | 1.33 | $ 153.73M |
| 9/30/2023 | $ 126.17M | 2.59 | $ 48.64M |
| 6/30/2023 | $ 262.69M | 4.62 | $ 56.87M |
| 3/31/2023 | $ 355.25M | 4.77 | $ 74.55M |
Key Performance Insights, Last 5 Years
- SUTRO BIOPHARMA INC's latest trailing twelve months (TTM) P/S stands at 12.16.
- Over the past 5 years, SUTRO BIOPHARMA INC's average P/S has been 6.72.
- The median P/S for SUTRO BIOPHARMA INC during this period was 4.53
- SUTRO BIOPHARMA INC reached its highest P/S over the past 5 years at 25.71.
- The lowest P/S recorded by SUTRO BIOPHARMA INC in the same timeframe 0.65
SUTRO BIOPHARMA INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for SUTRO BIOPHARMA INC is calculated as follows: Market Cap [ $ 556.29M ] / Revenues [ $ 45.75M ]
(=) P/S [ 12.16 ] STRO - Price to Sales, Last 5 years
0.65
Minimum
Jun 30, 2025
25.71
Maximum
Dec 31, 2020
6.72
Average
4.53
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |